The role of estrogen receptors in Alzheimer?s disease
The role of estrogen receptors in Alzheimer?s disease
批准号:
8335497
负责人:
Rena Li
金额:
$30.33万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-15 至 2014-06-30
关键词:
Age-MonthsAgingAging-Related ProcessAlzheimer disease preventionAlzheimer&aposs DiseaseAnimal ModelAppearanceBrainBrain PathologyBreedingCell LineCell physiologyCellsDNADataDetergentsDevelopmentDiseaseEnzymesEstrogen Receptor alphaEstrogen Receptor betaEstrogen ReceptorsEstrogen TherapyEstrogensExhibitsFemaleGene Expression RegulationGene TargetingGeneticGenetic TranscriptionGoalsHumanIn VitroInsulinaseKnockout MiceKnowledgeLeadLearningMemoryMemory LossMenopauseMolecularMusNeprilysinNerve DegenerationNeurodegenerative DisordersNeuronsPathologyPathway interactionsPatientsPhysiologyPike fishProcessProductionProtein IsoformsPublicationsRegulationResearchResponse ElementsRoleScreening procedureSenile PlaquesSignal PathwaySignal Transduction PathwayTestingTherapeutic InterventionTranscription Factor AP-1Transgenic AnimalsTransgenic MiceTransgenic Organismsamyloid pathologyamyloid precursor protein processingbeta secretasebeta-site APP cleaving enzyme 1cognitive functionin vivomalemouse modelneuroblastoma cellneuropathologynormal agingpreventpromoterprotein expressionreceptorreceptor functionsecretasetransgenic model of alzheimer disease
中文摘要
多年来,研究表明,大脑中的雌激素和雌激素受体
对神经细胞功能至关重要,但信号通路和调节
控制雌激素功能的机制仍然主要不清楚。它一般都是
认为女性绝经后雌激素的减少有助于
阿尔茨海默病等神经退行性疾病的发展
(Ad)。有一个密集的搜索与雌激素有关的疗法,可能
提供显著的好处,同时避免与
雌激素疗法。在许多这样的方法中,转录调控
大脑雌激素受体的功能是最普遍的调节形式
细胞功能,尽管我们对雌激素受体在
广告是非常有限的。最近,研究表明,这两种雌激素受体,
α和β(ER和ER)在衰老过程中可能具有不同的功能
阿尔茨海默病的生理学和预防(Yamaguchi-Shima 2007,Porrello等人)。2006年,
Corbo等人。2006年,Pirskanen等人。2005,Yaffe K 2007,Combarros 2007,Carroll
和派克,2008)。我们最近的研究表明大脑中雌激素的减少。
女性阿尔茨海默病患者的雌激素受体水平和ER?蛋白表达(Yue等人)2005)。
然而,对大脑的细胞和分子功能知之甚少。
ER?和ER?以及它们的功能丧失如何导致AD的神经变性。
雌激素受体预防预防作用的分子机制研究
AD,我们将使用基因打靶的方法来删除其中一个受体,
在阿尔茨海默病转基因小鼠模型APP23中定义ER?或ER?
每种雌激素受体在AD神经元保护和APP处理中的作用。
在这个方案中,我们将检验大脑ER?和ER?是
参与不同的抗淀粉样蛋白信号转导通路
阿尔茨海默病大脑的病理和认知功能。
英文摘要
For years, studies have shown that brain estrogen and estrogen receptors
are critical for neuronal cell functions, yet the signal pathways and regulatory
mechanisms that control estrogen function remain main unclear. It is generally
believed that the reduction of estrogen after menopause in females contributes to
the development of neurodegenerative diseases such as Alzheimer's disease
(AD). There is an intense search for therapies related to estrogen that might
provide significant benefits while avoiding the negative aspects associated with
estrogen therapy. Among many such approaches, the transcriptional regulatory
function of brain estrogen receptors is the most prevalent form of regulatory
cellular function, although our knowledge about the role of estrogen receptors in
AD is very limited. Recently, studies have shown that the two estrogen receptors,
alpha and beta (ER¿ and ER¿), may have different functions in term of aging
physiology and prevention of AD (Yamaguchi-Shima 2007, Porrello et al. 2006,
Corbo et al. 2006, Pirskanen et al. 2005, Yaffe K 2007, Combarros 2007, Carroll
and Pike, 2008). Our recent studies demonstrated a reduction in brain estrogen
levels as well as ER¿ protein expression in female AD patients (Yue et al. 2005).
However, very little are known about the cellular and molecular functions of brain
ER¿ and ER¿ and how loss of their functions causes neurodegeneration in AD.
To identify the molecular mechanisms of estrogen receptor function in preventing
AD, we will use a gene-targeting approach to delete either one of the receptors,
ER¿ or ER¿ in an Alzheimer's transgenic mouse model, APP23, to define the
role of each estrogen receptor in neuronal protection and APP processing in AD.
In this proposal, we will test the hypothesis that brain ER¿ and ER¿ are
involved in distinct signal transduction pathways against amyloid
pathology and cognitive functions in the AD brain.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1523/jneurosci.1180-10.2010
发表时间:
2010-05-26
期刊:
The Journal of neuroscience : the official journal of the Society for Neuroscience
影响因子:
--
作者:
[McAllister C, Long J, Bowers A, Walker A, Cao P, Honda S, Harada N, Staufenbiel M, Shen Y, Li R]
通讯作者:
Li R
Mini Review: linkages between essential tremor and Parkinson's disease?
迷你回顾:原发性震颤与帕金森病之间的联系?
DOI:
10.3389/fncel.2013.00118
发表时间:
2013
期刊:
Frontiers in cellular neuroscience
影响因子:
5.3
作者:
[Wu,Yiwen, Ding,Jianqing, Gao,Yuan, Chen,Shangdi, Li,Li, Li,Rena]
通讯作者:
Li,Rena
DOI:
10.18632/oncotarget.13962
发表时间:
2017-01-17
期刊:
Oncotarget
影响因子:
--
作者:
[Zhang X, Yang J, Li Y, Ma X, Li R]
通讯作者:
Li R
DOI:
10.1186/2047-9158-2-21
发表时间:
2013-10-12
期刊:
Translational neurodegeneration
影响因子:
12.6
作者:
[Shen Y, Yang L, Li R]
通讯作者:
Li R
BACE1-Dependent Neuregulin-1 Signaling: An Implication for Schizophrenia.
BACE1 依赖性 Neuregulin-1 信号转导:对精神分裂症的影响
DOI:
10.3389/fnmol.2017.00302
发表时间:
2017
期刊:
Frontiers in molecular neuroscience
影响因子:
4.8
作者:
[Zhang Z, Huang J, Shen Y, Li R]
通讯作者:
Li R
共 12 条
PATHOBIOLOGICAL STUDIES OF VESSEL BACE1 IN CEREBROVASCULAR AMYLOID ANGIOPATHY
-
批准号:9174461
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2016
-
负责人:Rena Li
-
依托单位:
The role of estrogen receptors in Alzheimer?s disease
-
批准号:7915404
-
项目类别:
-
资助金额:$16.08万
-
财政年份:2009
-
负责人:Rena Li
-
依托单位:
The role of estrogen receptors in Alzheimer?s disease
-
批准号:8197400
-
项目类别:
-
资助金额:$30.33万
-
财政年份:2009
-
负责人:Rena Li
-
依托单位:
The role of estrogen receptors in Alzheimer?s disease
-
批准号:8185904
-
项目类别:
-
资助金额:$19.03万
-
财政年份:2009
-
负责人:Rena Li
-
依托单位:
The role of estrogen receptors in Alzheimer?s disease
-
批准号:7737731
-
项目类别:
-
资助金额:$35.47万
-
财政年份:2009
-
负责人:Rena Li
-
依托单位:
海外基金